0001209191-23-057276.txt : 20231204
0001209191-23-057276.hdr.sgml : 20231204
20231204172508
ACCESSION NUMBER: 0001209191-23-057276
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231204
DATE AS OF CHANGE: 20231204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaSpaluto Michelle
CENTRAL INDEX KEY: 0002001106
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 231464437
MAIL ADDRESS:
STREET 1: C/O CHIMERIX, INC.
STREET 2: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-12-01
0
0001117480
CHIMERIX INC
CMRX
0002001106
LaSpaluto Michelle
C/O CHIMERIX, INC.
2505 MERIDIAN PKWY, SUITE 100
DURHAM
NC
27713
0
1
0
0
Chief Financial Officer
Common Stock
87939
D
Stock Option (Right to Buy)
18.75
2024-01-27
Common Stock
9000
D
Stock Option (Right to Buy)
36.75
2024-12-03
Common Stock
750
D
Stock Option (Right to Buy)
39.41
2025-01-27
Common Stock
9000
D
Stock Option (Right to Buy)
53.74
2025-07-31
Common Stock
1500
D
Stock Option (Right to Buy)
53.74
2025-07-31
Common Stock
15000
D
Stock Option (Right to Buy)
8.06
2026-01-07
Common Stock
18700
D
Stock Option (Right to Buy)
4.51
2026-12-14
Common Stock
1250
D
Stock Option (Right to Buy)
4.68
2028-01-24
Common Stock
13000
D
Stock Option (Right to Buy)
2.41
2029-01-22
Common Stock
8098
D
Stock Option (Right to Buy)
2.49
2029-09-25
Common Stock
48438
D
Stock Option (Right to Buy)
2.08
2020-01-21
2030-01-20
Common Stock
62067
D
Stock Option (Right to Buy)
9.28
2021-01-22
2031-01-21
Common Stock
90000
D
Stock Option (Right to Buy)
5.62
2022-01-18
2032-01-17
Common Stock
95000
D
Stock Option (Right to Buy)
1.97
2023-01-17
2033-01-16
Common Stock
64275
D
Amount includes 10,725 unvested shares pursuant to a restricted stock unit award issued on January 17, 2023.
Fully vested and exercisable.
1/48th of the shares will vest each month over a four year period following the vesting commencement date. This stock option was previously exercised as to 25,933 shares.
1/48th of the shares will vest each month over a four year period following the vesting commencement date.
/s/ Michael Alrutz, Attorney-in-Fact
2023-12-04
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Michael Andriole and Michael Alrutz of Chimerix, Inc. (the "Company"),
signing individually, the undersigned's true and lawful attorney-in fact and
agent to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of the Company, Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact
shall no longer be employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 4th day of December, 2023.
/s/ Michelle LaSpaluto
MICHELLE LASPALUTO